ArticleMolecular & cellular oncology2016

Epigenetic inhibition of adaptive bypass responses to lapatinib by targeting BET Bromodomains.

Timothy J Stuhlmiller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.